Human Biomonitoring for Bisphenol A (BPA)

<p>
<ol>
<li>Develop and implement sensitive and selective analytical methodology to measure BPA from blood and urine samples from children and adults with known exposures.</li>
<li>Integrate human biomonitoring data with pharmacokinetic data from animals and humans to produce a physiologically based pharmacokinetic (PBPK) model for BPA to empower FDA to reach science-based decisions about risks, particularly to children and fetuses, from medical devices, food contact materials, and other environmental exposures.</li></ol></p>